Structures by: Moumou M.
Total: 21
Ethyl 10α-hydroxy-4,9-dimethyl-14-oxo-3,8,15-trioxatetracyclo[10.3.0.0^2,4^.0^7,9^]pentadecane-13-spiro-5-pyrazole-3'-carboxylate
C25H29ClN2O7
IUCrData (2020) 5, 7 x200945
a=9.2324(3)Å b=11.1656(4)Å c=23.3497(8)Å
α=90° β=90° γ=90°
9β-Hydroxy-1β,10α-epoxyparthenolide
C15H20O5
Acta Crystallographica Section E (2010) 66, 9 o2395
a=9.2295(3)Å b=9.5431(3)Å c=9.3787(3)Å
α=90.00° β=118.662(2)° γ=90.00°
9α-Acetoxy-1β,10α-epoxyparthenolide
C17H22O6
Acta Crystallographica Section E (2010) 66, 12 o3239
a=8.2390(3)Å b=10.6482(4)Å c=9.4633(3)Å
α=90.00° β=102.039(2)° γ=90.00°
2-Isopropyl-4-methoxy-5-methylphenyl benzoate
C18H20O3
Acta Crystallographica Section E (2010) 66, 4 o850
a=8.4765(4)Å b=8.0880(4)Å c=23.8119(11)Å
α=90.00° β=98.202(2)° γ=90.00°
(1<i>S</i>,2<i>R</i>,3<i>R</i>,8<i>R</i>,10<i>S</i>)-3-Chloro-2,8- dihydroxy-3,7-dimethyl-11-methylidene-13-oxabicyclo[8.3.0]tridec-6-en-12-one
C15H21ClO4
Acta Crystallographica Section E (2011) 67, 11 o2826-o2827
a=8.0224(2)Å b=12.1532(2)Å c=15.4147(4)Å
α=90.00° β=90.00° γ=90.00°
10αHydroxy-4,9-dimethyl-13-[(4-phenylpiperazin-1-yl)methyl]- 3,8,15-trioxatetracyclo[10.3.0.0^2,4^.0^7,9^]tetradecan-14-one
C25H34N2O5
Acta Crystallographica Section E (2011) 67, 11 o2981-o2982
a=7.7666(5)Å b=9.6059(8)Å c=31.181(2)Å
α=90.00° β=90.00° γ=90.00°
10α-Hydroxy-4,9-dimethyl-13-[(pyrrolidin-1-yl)methyl]-3,8,15- trioxatetracyclo[10.3.0.0^2,4^.0^7,9^]pentadecan-14-one
C19H29NO5
Acta Crystallographica Section E (2011) 67, 7 o1842-o1843
a=8.0714(2)Å b=10.4571(3)Å c=21.5816(8)Å
α=90.00° β=90.00° γ=90.00°
5,9-Dihydroxy-9-methyl-3,6-dimethylene-3a,4,5,6,6a,7,8,9,9a,9b- decahydroazuleno[4,5-<i>b</i>]furan-2(3<i>H</i>)-one
C15H20O4
Acta Crystallographica Section E (2011) 67, 7 o1760-o1761
a=6.4210(14)Å b=13.504(3)Å c=15.619(3)Å
α=90.00° β=90.00° γ=90.00°
10α-Hydroxy-4,9-dimethyl-13-(pipyridin-1-ylmethyl)-3,8,15- trioxatetracyclo[10.3.0.0^2,4^.0^7,9^]tetradecan-14-one
C20H31NO5
Acta Crystallographica Section E (2011) 67, 11 o3003-o3004
a=8.0899(5)Å b=10.7562(6)Å c=22.5093(13)Å
α=90.00° β=90.00° γ=90.00°
10α-Hydroxy-13-{[4-(4-methoxyphenyl)piperazin-1-yl]methyl}-4,9-dimethyl- 3,8,15-trioxatetracyclo[10.3.0.0^2,4^.0^7,9^]pentadecan-14-one
C26H36N2O6
Acta Crystallographica Section E (2012) 68, 3 o715-o716
a=8.0770(7)Å b=10.2667(10)Å c=28.937(3)Å
α=90.00° β=90.00° γ=90.00°
10α-Hydroxy-13-{[4-(2-hydroxyphenyl)piperazin-1-yl]methyl}-4,9-dimethyl- 3,8,15-trioxatetracyclo[10.3.0.0^2,4^.0^7,9^]pentadecan-14-one
C25H34N2O6
Acta Crystallographica Section E (2012) 68, 5 o1309-o1310
a=8.0978(2)Å b=10.3660(3)Å c=28.8194(8)Å
α=90.00° β=90.00° γ=90.00°
5,8-Dimethyl-3-methylene-2-oxo-3,3a,4,5,5a,6,8a,8b-octahydro- 2<i>H</i>-1-oxa-s-indacene-5-carbaldehyde
C15H18O3
Acta Crystallographica Section E (2011) 67, 6 o1479
a=9.5293(3)Å b=9.7885(3)Å c=13.7524(4)Å
α=90.00° β=90.00° γ=90.00°
12-Anilinomethyl-9α-hydroxy-4,8-dimethyl-3,14- dioxatricyclo[9.3.0.0^2,4^]tetradec-7-en-13-one
C21H27NO4
Acta Crystallographica Section E (2011) 67, 6 o1388-o1389
a=11.1067(8)Å b=11.9406(9)Å c=14.6930(11)Å
α=90.00° β=106.315(2)° γ=90.00°
(<i>Z</i>)-6-Hydroxy-1a,5-dimethyl-8-[(morpholin-4-yl)methyl]- 2,3,6,7,7a,8,10a,10b-octahydrooxireno[2',3':9,10]cyclodeca[1,2-<i>b</i>]furan- 9(1a<i>H</i>)-one
C19H29NO5
Acta Crystallographica Section E (2011) 67, 7 o1698-o1699
a=11.7539(3)Å b=6.8304(2)Å c=11.8585(3)Å
α=90.00° β=101.328(2)° γ=90.00°
9-Hydroxy-4,8-dimethyl-12-(pyrrolidin-1-ylmethyl)-3,14- dioxatricyclo[9.3.0.0^2,4^]tetradec-7-en-13-one
C19H29NO4
Acta Crystallographica Section E (2011) 67, 9 o2226-o2227
a=8.1389(6)Å b=10.1788(7)Å c=21.7669(15)Å
α=90.00° β=90.00° γ=90.00°
9-Hydroxy-4,8-dimethyl-12-(piperidin-1-ylmethyl)-3,14-dioxatricyclo [9.3.0.0^2,4^]tetradec-7-en-13-one
C20H31NO4
Acta Crystallographica Section E (2011) 67, 10 o2768-o2769
a=11.8390(6)Å b=6.7053(3)Å c=12.0875(6)Å
α=90.00° β=101.399(5)° γ=90.00°
10α-Hydroxy-4,9-dimethyl-13-(morpholin-4-ylmethyl)-3,8,15- trioxatetracyclo[10.3.0.0^2,4^.0^7,9^]pentadecan-14-one
C19H29NO6
Acta Crystallographica Section E (2012) 68, 1 o167-o168
a=11.6772(9)Å b=6.9524(4)Å c=11.8244(9)Å
α=90.00° β=102.160(2)° γ=90.00°
9β-Hydroxy-6,9-dimethyl-3-methylene-3a,4,8,9,9a,9b- hexahydroazuleno[4,5-<i>b</i>]furan-2(3<i>H</i>)-one
C15H18O3
Acta Crystallographica Section E (2012) 68, 2 o386
a=15.6732(9)Å b=7.4208(4)Å c=11.0544(6)Å
α=90.00° β=103.169(6)° γ=90.00°
12-{[4-(2-Fluorophenyl)piperazin-1-yl]methyl}-9α-hydroxy-4,8-dimethyl- 3,14-dioxatricyclo[9.3.0.0^2,4^]tetradec-7-en-13-one
C25H33FN2O4
Acta Crystallographica Section E (2012) 68, 3 o741-o742
a=14.583(2)Å b=6.3366(17)Å c=24.697(3)Å
α=90.00° β=93.598(14)° γ=90.00°
9α-Hydroxy-12-{[4-(4-methoxyphenyl)piperazin-1-yl]methyl}-4,8-dimethyl- 3,14-dioxatricyclo[9.3.0.0^2,4^]tetradec-7-en-13-one
C26H36N2O5
Acta Crystallographica Section E (2012) 68, 3 o589-o590
a=6.7066(7)Å b=11.9033(11)Å c=30.322(4)Å
α=90.00° β=90.00° γ=90.00°
(1<i>S</i>,2<i>R</i>,3<i>R</i>,6<i>R</i>,7<i>S</i>,8<i>R</i>, 10<i>S</i>,11<i>S</i>)-13-{[4-(4-Chlorophenyl)piperazin-1-yl]methyl}- 10-hydroxy-4,9-dimethyl-3,8,15- trioxatetracyclo[10.3.0.0^2,4^.0^7,9^]pentadecan-14-one
C25H33ClN2O5
Acta Crystallographica Section E (2012) 68, 4 o1147-o1148
a=8.0138(3)Å b=10.7218(5)Å c=28.0174(13)Å
α=90.00° β=90.00° γ=90.00°